Repeated Favorable Responses to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in a Case of Advanced Lung Adenocarcinoma

The presence of epidermal growth factor receptor (EGFR) mutation is a prognostic and predictive marker for EGFR-tyrosine kinase inhibitor (TKI) therapy. However, inevitably, relapse occurs due to the development of acquired resistance, such as T790M mutation. We report a case of repeated responses t...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Kim, Eun-Young, Kim, Yoon-Hee, Ban, Hee-Jung, Oh, In-Jae, Kwon, Yong-Soo, Kim, Kyu-Sik, Kim, Yu-Il, Lim, Sung-Chul, Kim, Young-Chul
Formato: Artigo
Idioma:Inglês
Publicado: The Korean Academy of Tuberculosis and Respiratory Diseases 2013
Assuntos:
Case Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3617133/
https://ncbi.nlm.nih.gov/pubmed/23579627
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4046/trd.2013.74.3.129
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares